1 – 10 of 62
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease
Ossenkoppele, Rik LU ; Lyoo, Chul Hyoung ; Sudre, Carole H. ; van Westen, Danielle LU
;
Cho, Hanna
;
Ryu, Young Hoon
;
Choi, Jae Yong
;
Smith, Ruben
LU
;
Strandberg, Olof
LU
and
Palmqvist, Sebastian
LU
, et al.
(2020)
In Alzheimer's and Dementia
16(2).
p.335-344
Mark
-
Assessment of Demographic, Genetic, and Imaging Variables Associated with Brain Resilience and Cognitive Resilience to Pathological Tau in Patients with Alzheimer Disease
Ossenkoppele, Rik LU ; Lyoo, Chul Hyoung ; Jester-Broms, Jonas LU ; Sudre, Carole H. ; Cho, Hanna ; Ryu, Young Hoon ; Choi, Jae Yong ; Smith, Ruben LU ; Strandberg, Olof LU and Palmqvist, Sebastian LU
, et al.
(2020)
In JAMA Neurology
Mark
- Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease
-
Brief Cognitive Tests Used in Primary Care Cannot Accurately Differentiate Mild Cognitive Impairment from Subjective Cognitive Decline
Petrazzuoli, Ferdinando LU
;
Vestberg, Susanna
LU
;
Midlöv, Patrik
LU
;
Thulesius, Hans
LU
;
Stomrud, Erik
LU
and
Palmqvist, Sebastian
LU
(2020)
In Journal of Alzheimer's disease : JAD
Mark
-
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
Janelidze, Shorena LU ; Stomrud, Erik LU ; Smith, Ruben LU ; Palmqvist, Sebastian LU
;
Mattsson, Niklas
LU
;
Airey, David C.
;
Proctor, Nicholas K.
;
Chai, Xiyun
;
Shcherbinin, Sergey
and
Sims, John R.
, et al.
(2020)
In Nature Communications
11(1).
Mark
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease : a diagnostic performance and prediction modelling study using data from four prospective cohorts
-
Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease from Other Neurodegenerative Disorders
Leuzy, Antoine LU ; Smith, Ruben LU ; Ossenkoppele, Rik LU ; Santillo, Alexander LU
;
Borroni, Edilio
;
Klein, Gregory
;
Ohlsson, Tomas
;
Jögi, Jonas
LU
;
Palmqvist, Sebastian
LU
and
Mattsson-Carlgren, Niklas
LU
, et al.
(2020)
In JAMA Neurology
Mark
-
Plasma P-tau181 in Alzheimer’s disease : relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
Janelidze, Shorena LU ; Mattsson, Niklas LU ; Palmqvist, Sebastian LU
;
Smith, Ruben
LU
;
Beach, Thomas G.
;
Serrano, Geidy E.
;
Chai, Xiyun
;
Proctor, Nicholas K.
;
Eichenlaub, Udo
and
Zetterberg, Henrik
LU
, et al.
(2020)
In Nature Medicine
26(3).
p.379-386
Mark
-
The age-related effect on cognitive performance in cognitively healthy elderly is mainly caused by underlying AD pathology or cerebrovascular lesions : implications for cutoffs regarding cognitive impairment
Borland, Emma LU
;
Stomrud, Erik
LU
;
van Westen, Danielle
LU
;
Hansson, Oskar
LU
and
Palmqvist, Sebastian
LU
(2020)
In Alzheimer's Research & Therapy
12(1).
Mark
-
The implications of different approaches to define AT(N) in Alzheimer disease
Mattsson-Carlgren, Niklas LU ; Leuzy, Antoine LU ; Janelidze, Shorena LU ; Palmqvist, Sebastian LU
;
Stomrud, Erik
LU
;
Strandberg, Olof
LU
;
Smith, Ruben
LU
and
Hansson, Oskar
LU
(2020)
In Neurology
94(21).
p.2233-2244
Mark